Antianginal Agent Flashcards
Brand Name for Ranolazine
Ranexa
dosage form for Ranolazine (Ranexa)
Oral tablet, ER 12h : 500mg and 1000mg
Indication for Ranolazine?
Chronic angina
(sig: initial 500 mg po bid, may titrate to max dose of 1000mg bid
Ranolazine MOA?
Ranolazine inhibits the late phase of the inward sodium channel during cardiac repolarization reducing intracellular sodium concentrations and thereby reducing calcium influx via Na+-Ca2+ exchange that in turn reduces ventricular tension and myocardial oxygen consumption.
Ranolazine contraindication?
Hepatic cirrhosis, strong CYP3A4/5 inducers or inhibitors, P-gp inhibitors
Common ADR?
None
Less Common ADR?
Dizziness, headache, bradycardia, hypotension, edema, constipation, nausea, xerostomia, blurred vision
Serious ADR?
Angioedema, pancytopenia (lower than normal of RBC and WBC and platelets in the blood), pulmonary fibrosis, arrhythmia, renal failure, syncope, QTc prolongation
Ranolazine Monitoring Parameters?
Efficacy: Improvement in angina symptoms, improved exercise tolerance
Toxicity: Baseline and follow-up ECG to evaluate QTc if concerns for prolongation; monitor BP and renal function at baseline and periodically.
Key counseling points?
Do not crush or chew but may be taken with or without meals. There are multiple significant drug interactions so talk to HCP before starting any new medications or herbal supplements. Ranolazine will not stop an acute angina episode.
may use in combination with beta-blockers or alone in pt who do not respond to or tolerate beta-blockers